Journal of lower genital tract disease

Journal of lower genital tract disease
Audio Summaries

Every issue of Journal of lower genital tract disease moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.

99 audio summariesNLM Catalog

Specialties

Journal of lower genital tract disease covers research in these specialties.

Recent summaries

The latest articles summarized from Journal of lower genital tract disease.

Efficacy of Cryotherapy Compared With Loop Electrosurgical Excision Procedure Among Women With and Without HIV in Kenya.

Nov 16, 2026

This study compared treatment failure rates of cryotherapy and LEEP for cervical intraepithelial neoplasia among women with and without HIV in Western Kenya. Women with HIV had significantly higher overall failure rates than women without HIV (15.1% vs 5.6%), and this gap was largest after cryotherapy (18% vs 2.1%), while LEEP failure rates did not differ significantly between groups (12.8% vs 9.3%). The authors conclude that LEEP is a more effective treatment than cryotherapy for women with HIV.

Clinical Utility of Trichomonas vaginalis Reported on Cervical Cytology.

Nov 12, 2026

This study evaluated whether Trichomonas vaginalis identified incidentally on liquid-based cervical cytology is reliable enough to act on, by testing 200 cytology-positive specimens with T. vaginalis-specific NAATs. All specimens were confirmed, giving a PPV of 100%, but among eligible patients only 4.8% received confirmatory testing and 53.2% were treated within 2 months. The authors conclude that cytology findings are highly accurate and that greater visibility of these results in reports is needed to prevent missed treatment opportunities.

Recurrence Rate of Genital Warts Between Treatment With Imiquimod and Polyphenon E: A Systematic Review.

Nov 2, 2026

This systematic review asked whether recurrence rates of genital warts differ between treatment with imiquimod 5% and Polyphenon E (10% or 15%). Across 12 included trials, recurrence estimates varied widely (imiquimod 5%: 0% to 28.6%, mostly 12.5% to 19%; Polyphenon E: about 4% to 12%), but because the evidence was indirect and heterogeneous, the authors could not draw a comparative conclusion and call for head-to-head trials.

Effect of Solution-focused Outpatient Follow-up on Post-surgery Resilience and Sexual QoL in Cervical Cancer.

Oct 28, 2026

This retrospective cohort study of 115 cervical cancer patients asked whether an outpatient solution-focused follow-up program is associated with better postoperative psychological resilience and sexual quality of life. Compared with controls, the intervention group had significantly higher resilience (CD-RISC 72.6 vs 64.2), better sexual function (FSFI 26.9 vs 23.2), and less sexual distress (FSDS 8.9 vs 12.1) at 6 months, with consistent benefits in anxiety, depression, overall quality of life, and self-efficacy. Because the design is retrospective and observational, the findings show association rather than proof of causal benefit.

Adverse Events Associated With Treatment for Anal High-Grade Squamous Intraepithelial Lesions: A Systematic Review.

Oct 27, 2026

This systematic review asked what adverse events occur with treatments for anal high-grade squamous intraepithelial lesions (HSIL) and how well they are reported. Across 42 studies (mostly in men living with HIV), pain and bleeding were the most common events, with ablative therapies linked to pain and radiofrequency ablation to high bleeding rates. The authors found that AE reporting is inconsistent and poorly standardized (only 2 studies used validated instruments), so they call for validated definitions, structured reporting tools, core outcome sets, and larger comparative randomized trials.

Toward Safer Regenerative, Functional, and Aesthetic Gynecology: A Clinical Governance Framework for Patient Safety.

Oct 27, 2026

This narrative review asks how to reduce complications in regenerative, functional, and aesthetic gynecology, and argues that safety depends mainly on clinical decision-making rather than on the specific technology used. The authors propose a multidimensional governance framework built on patient factors (such as hormonal status, tissue quality, and expectations), clinician factors (diagnostic accuracy, anatomic expertise, and willingness to decline intervention), and procedural factors (technique, standardization, and follow-up). They conclude that rigorous patient selection, endocrine optimization when indicated, evidence-based indications, competency-based training, and strong clinical governance are essential to the subspecialty's credibility.

Contemporary High-risk Human Papillomavirus Genotype Distribution and Associated Cytologic Findings Using Extended Human Papillomavirus Genotyping.

Oct 23, 2026

This study examined genotype-specific high-risk HPV infections and their associated Pap cytology results over one year (2024) at a laboratory using an assay that detects 14 hrHPV genotypes, with 6 typed individually and 8 grouped into 3 pools. Among 3,015 hrHPV-positive cases, most were single-genotype infections, and HPV16 and HPV18 were most strongly linked to high-grade lesions, while pooled non-16/18 genotypes (comprising nearly half of positives) were mainly associated with negative, ASC-US, or LSIL cytology. The findings support extended genotyping for risk stratification and monitoring of evolving HPV epidemiology in the postvaccination era.

Diagnostic Pathways for Anal Dysplasia in Men Living With HIV at a Single Urban HIV Center: A 30-Year Review.

Oct 19, 2026

This retrospective cohort study of 347 cisgender men who have sex with men living with HIV at a single urban clinic (1993–2023) examined how anal dysplasia was first identified before standardized screening guidelines. Of the 47 cases (13.5%), most were found through direct diagnostic evaluation (53%), followed by prior anal cytology (36%) and incidental detection (11%), and among cytology-first cases, 60% of those with abnormal results completed colorectal surgery follow-up. The findings provide a pre-guideline baseline for assessing future implementation of guideline-concordant anal cancer screening in HIV care.

A Pragmatic Review of Colposcopy and LLETZ (Large Loop Excision of the Transformation Zone) Simulation Models.

Oct 15, 2026

This pragmatic review asks whether simulation-based training is an effective tool for teaching colposcopy and LLETZ/LEEP, procedures that have been far less studied than hysteroscopy or laparoscopy. Across 13 studies (2012-2023), simulation improved participants' satisfaction, confidence, knowledge, and performance scores, though assessment methods varied widely and only one study examined transfer to real clinical practice. The authors conclude there is promising evidence for simulation in these gynecology procedures, particularly for skill and knowledge gains, and suggest that gender-based health inequity may partly explain the limited research in this area.

Call to Action: Pain Management at the Time of Colposcopy: It Should Be Routinely Offered.

Oct 12, 2026

This commentary asks whether pain-management options should be routinely discussed and offered to patients undergoing colposcopy with biopsies or endocervical sampling. Drawing on randomized trials, systematic reviews, and professional guidance, the author finds that topical lidocaine and injected local anesthesia reduce biopsy pain, though evidence is heterogeneous and no single regimen is clearly optimal. The author concludes that because pain varies unpredictably among patients, anesthesia options should be routinely offered as a standard component of colposcopic care.

Listen to Journal of lower genital tract disease

14-day free trial. Every new article, summarized in ~3 minutes.